How to Buy Biolase Stock
Biolase Inc
BIOLASE, Inc. , together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.
Biolase stock last closed at $0.08, up 1.25% from the previous day, and has decreased 98.3% in one year. It has underperformed other stocks in the Medical Devices industry by 0.96 percentage points. Biolase stock is currently +14.08% from its 52-week low of $0.07, and -98.64% from its 52-week high of $5.94.
At the moment, there are 27.73M shares of BIOL outstanding. The market capitalization of BIOL is $2.25M. In the last 24 hours, 8.87M BIOL shares were traded.
How to Buy Biolase Stock
Not sure how to invest in Biolase stock? Here's how.
- Decide where to buy Biolase stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Biolase stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your method of payment and add your information.
- Evaluate Biolase stock: The Biolase ticker symbol is BIOL. Is Biolase stock a good investment? Should you buy shares of BIOL? How do BIOL's underlying business fundamentals look? Do top analysts think Biolase is a good buy? Why has BIOL's stock price moved recently? (Hint: Our stock research website can help you figure out if BIOL is a good stock to buy).
- Execute your BIOL purchase: Decide if you will purchase BIOL shares at the current market price or use a limit order to purchase BIOL stock at a given price.
- Keep tabs on your BIOL position: Create a watchlist to the latest updates on your position in Biolase shares.
Step 1: Decide where to buy Biolase stock
You need an online brokerage account to access the NASDAQ market and buy BIOL shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you are able to buy BIOL today.
How to Start a New Account on eToro
- Click here to get started.
- Provide your personal details to start a new brokerage account.
- Send your details by clicking the "Create Account" button.
Step 3: Put funds into your investment account
Now that you have opened your account on the best stock app for beginners, you need to deposit funds:
Watch the tutorial below for more details depositing money into your brokerage account.
Step 4: Evaluate Biolase stock
Once you have chosen the best place to buy Biolase stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the upside.
Biolase Metrics
Fundamentals of BIOL
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on BIOL's stock page.
How is BIOL stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge BIOL's intrinsic value.
Using relative valuations ratios:
- BIOL could be undervalued based on its P/B ratio of 0.28x, relative to Medical Devices industry P/B ratio of 3.87x
You can do additional valuation research on BIOL's stock here.
BIOL Financial Overview
Signs that BIOL is financially healthy:
- There are more short-term assets than short-term liabilities on the BIOL balance sheet.
- There are more short-term assets than long-term liabilities on the BIOL balance sheet.
Signs that BIOL is not financially healthy:
- BIOL has $6.53M in cash and short term investments. This is not enough to cover its annual cash burn of $28.41M.
- BIOL has cash burn of 28408000. It does not have sufficient cash and short-term investments to cover this.
- BIOL profit margin has gone down from -34.6% to -60.9% in the past year.
- Total BIOL debt is higher than 5 years ago, relative to shareholder equity.
- BIOL has a relatively high debt to equity ratio of 4.14.
Do Wall Street analysts think it's a good time to buy BIOL stock
Out of 3 Equities analysts who give ratings on BIOL, the consensus analyst rating on BIOL is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest BIOL Analyst Forecasts
Anthony Vendetti, a bottom 5% analyst from Maxim Group maintains BIOL with a strong buy rating and lowers their BIOL price target from $5.00 to $1.00, on Mar 29, 2023.
Bruce Jackson, a bottom 7% analyst from Benchmark reiterates BIOL with a buy rating and maintains their BIOL price target from $2.00 to $2.00, on Mar 29, 2023.
Frank Takkinen, a bottom 2% analyst from Lake Street assumes BIOL with a strong buy rating and announces their BIOL price target of $1.50, on Jan 20, 2023.
You can dig deeper into what analysts are forecasting on the Biolase stock forecast page.
BIOL Momentum
BIOL Performance Metrics
Last year, BIOL revenue was $48.76M. Over the past five year, BIOL's revenue has grown by 1.14% per year. This was slower than the Medical Devices industry average of 12.46%.
Dive into BIOL's earnings and revenue performance here.
Are BIOL executives and large shareholders buying or selling the stock?
In the past 12 months, executives and large shareholders at BIOL have sold more shares than they have bought.
Jonathan T. Md Lord, Director of BIOL, was the latest BIOL insider to sell. They sold $2,652.75 worth of BIOL shares on Dec 7, 2022.
Get more info about who owns BIOL shares here.
Does BIOL stock generate passive income?
No, Biolase doesn't provide an income stream by paying out dividends.
What do other traders have to say about BIOL?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your BIOL purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
Step 6: Keep tabs on your BIOL position
Now that you own some shares in BIOL, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to get notified of the latest news about your BIOL stock.
BIOL Feed
How to Buy Stock in Biolase
To summarize, here are the 6 steps for buying Biolase stock:
- Decide where to buy Biolase stock
- Create a brokerage account
- Put funds into your investment account
- Evaluate Biolase stock
- Execute your BIOL purchase
- Keep tabs on your BIOL position
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Biolase, create a watchlist on WallStreetZen today.
Other Content You Might Find Useful
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.